Liver Disease

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Gastroenterology, Immunology

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology, Immunology

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

More News

November 21st 2022

MA Beneficiaries May Be at Disadvantage for Complex Cancer Surgeries

Patients with Medicare Advantage (MA) were 1.5 times more likely to die within a month of surgical removal of their stomach or liver, and twice as likely to die within a month of oncologic surgery of the pancreas, compared with patients with traditional Medicare.

November 3rd 2022

Change in Smoking Status and Subsequent BMI Change Linked to NAFLD Risk

Across 4 types of smoking status groups, nonalcoholic fatty liver disease (NAFLD) risk significantly increased among participants who saw an increase in body mass index (BMI) and decreased among participants whose BMI went down.

October 29th 2022

Second Liver Health Annual Trends Report Offers Insight Concerning CLD Management and Care

Pearl Steinzor

Challenges to the care of chronic liver disease (CLD) include the burden of costs, managed and multidisciplinary care issues, and the lack of awareness for clinical guidelines.

doctor writing on clipboard with stethoscope

October 26th 2022

New ICD-10 Code Aims to Provide More Insight Into Hepatic Encephalopathy

In an interview, the section chief of hepatology at Rush University Medical Center discussed why the addition of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code K76.82 is necessary.

October 26th 2022

What We’re Reading: Surge in Black, Latino ACA Enrollment; Medicaid Enrollment, Spending Trends; US Hepatitis C Treatment Plan

Black and Latino Americans saw surges in health care insurance enrollment through the Affordable Care Act (ACA) between 2020 and 2022; Medicaid enrollment and spending is expected to slow in 2023; the Biden administration is preparing a national hepatitis C treatment plan.

October 22nd 2022

Livers Can Function for 100 Years and Potentially Expand Pool of Eligible Donors

New research is identifying the recipient and donor factors that allow for greater longevity for certain livers after transplantation.

October 21st 2022

Albumin Injections Linked to Improved Brain Function, QOL in Patients With Liver Cirrhosis

Researchers also found an improvement in specialized blood markers focusing on inflammation, endothelial dysfunction, and albumin function in patients receiving weekly albumin injection.

close up of Europe on globe, shaded blue

October 15th 2022

European Report Highlights Health, Economic Impacts of Digestive Diseases

Chronic liver disease and pancreatitis were among the digestive diseases with high increases in incidence and mortality since 2000.

October 11th 2022

ICER to Assess Clinical Effectiveness, Value of 2 NASH Treatments

There are no FDA-approved therapies for nonalcoholic steatohepatitis (NASH), but there are many being developed. Resmetirom and obeticholic acid are both being reviewed by the FDA with decisions expected in 2023.

October 7th 2022

Higher Risk of Liver Disease Progression Seen Among Patients With PNPLA3 I148M Variant

Individuals who were homozygous carriers of the PNPLA3 I148M genetic variant and reported excessive drinking and obesity had a 17.5 to 30.1 higher risk of progression to liver disease complications.

doctor holding stethoscope to animated liver

September 27th 2022

NAFLD Linked to Increased Risk of Metabolic Syndrome in Patients Without MAFLD

Among individuals without metabolic-associated fatty liver disease (MAFLD), those with nonalcoholic fatty liver disease (NAFLD) had a higher risk of developing metabolic syndrome.

September 24th 2022

Study Identifies Gut Microbiota Linked to HE Pathophysiology

Urease-positive Streptococcus salivarius was the most significantly abundant gut microbiota in patients with HE.

September 22nd 2022

Dr Pichamol Jirapinyo Discusses Endoscopic Gastric Plication in Patients With NAFLD

Pichamol Jirapinyo, MD, MPH, director of bariatric endoscopy fellowship at Brigham and Women's Hospital, explains the implications of her study on the effects of endoscopic gastric plication on liver fibrosis in patients with nonalcoholic steatohepatitis (NASH).

September 16th 2022

Optimizing Emergency Care Processes Improves Outcomes for Hospitalized Patients With HE

Patients with hepatic encephalopathy (HE) often do not seek care until they are in critical condition, making an optimized emergency care process critical to reduce adverse prognosis and improve clinical symptoms.

September 14th 2022

Review Outlines Nutrition Assessment, Management in Patients With Cirrhosis

Julia Bonavitacola

A comprehensive review assessed the ways that proper nutrition could help reduce the adverse effects of hepatic encephalopathy in patients with hepatic encephalopathy.

silhouette of woman's face highlighting brain

September 9th 2022

Rifaximin Plus Lactulose Linked to Greater Effectiveness, Decreased Mortality in HE

Compared with the use of lactulose alone, rifaximin plus lactulose can provide additional benefits in terms of increased effectiveness rate and decreased mortality in patients with hepatic encephalopathy (HE).

September 3rd 2022

Evidence-Based Management Options for Hepatic Encephalopathy Explored in New Review

A review of 6 studies on treatment options for hepatic encephalopathy found that many require further research before they can be recommended.

September 2nd 2022

Liver Disease Disparities Rarely Studied in Europe, Review Finds

Jared Kaltwasser

A new analysis found only 1 in 10 studies of inequities in liver cancer had a European focus or origin.

June 3rd 2022

Individualized Antimicrobial Treatment, Prophylactic Regimens May Help With GVHD After Liver Transplant

Rose McNulty

A recent study aimed to provide insight and guidance for managing graft-versus-host disease in patients after liver transplantation.

May 31st 2022

Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients

Matthew Gavidia

US adult outpatients with psoriasis have a greater risk of developing nonalcoholic fatty liver disease compared with those without the skin condition.

February 14th 2022

ASTRO Offers Guidance on EBRT for Primary Liver Cancers

Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD

January 23rd 2022

Juan Pablo Frias, MD

In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.

December 28th 2021

Top 5 Most-Read Liver Disease Articles of 2021

Allison Inserro

Chronic liver disease is on the rise and the burden is expected to increase in the future, both in the United States and around the world. These are the most-read articles about liver disease in 2021.

December 22nd 2021

Posters Review Surveillance of Patients With NAFLD to Identify HCC

Two posters presented at The Liver Meeting evaluated nonalcoholic fatty liver disease (NAFLD)–associated hepatocellular carcinoma (HCC) to understand the burden and identify the risk for developing HCC.

December 19th 2021

Study Finds First-Degree Family History of Diabetes Linked With NAFLD

Using the fatty liver index (FLI) to identify nonalcoholic fatty liver disease (NAFLD), researchers sought to understand the association between first-degree family members of patients with diabetes and NAFLD.

December 13th 2021

Educational Interventions Are Needed to Address Knowledge Gaps for Management of NASH

Two posters presented at The Liver Meeting identified the primary care coordinators for patients with nonalcoholic steatohepatitis (NASH) and areas of unmet need among specialists to provide optimal management.

December 11th 2021

Evaluating Factors Impacting Health Disparities in Liver Transplant

Posters review how a patient’s neighborhood impacts access to the liver transplant waitlist and how Medicaid expansion improved waitlist mortality.

December 10th 2021

Dedicated Intervention Can Achieve Weight Loss in Patients With NALFD